ViVE and CHIME Wrap Up with Dr. Jayne 3/30/23
It was another busy couple of days at the conference. I had the opportunity to walk the show floor with a couple of friends yesterday and today as well as to hit a couple…
Continue ReadingIt was another busy couple of days at the conference. I had the opportunity to walk the show floor with a couple of friends yesterday and today as well as to hit a couple…
Continue ReadingMan fingers setting priority button on highest position. Concept image for illustration of priorities management.
Salt Lake City-based Intermountain Health is a nonprofit health, integrated healthcare system with clinics, a medical group, affiliate networks, hospitals,…
This week I’m in Nashville to experience the combined event that is CHIME and ViVE. I didn’t attend ViVE last year, but I heard stories about it, although Miami might have provided a different…
Continue ReadingStartUp Health, a 12-year old network of startups working in collaboration with healthcare stakeholders to develop solutions to some of the greatest challenges in healthcare, has some exciting developments planned for ViVE, the healthcare…
Continue ReadingWe are embarking on a new age for nursing assisted and enabled by technology and data. Many of us are embracing this prospect but others are sceptical and concerned about what this will mean…
Continue ReadingThe Interoperability pavilion is the place to be for innovators in healthcare at this year’s ViVE conference in Nashville, March 26-29 powered by CHIME and HLTH. How healthcare organizations share patient data won’t be…
Continue ReadingI’m headed to several conferences over the next two months. I spent some time this weekend going through the agendas and looking at the details to identify specific sessions I’d like to attend.
Smaller…
The series of attacks on our healthcare infrastructure, particularly hospitals where ransomware attacks are on the rise, is a worrying trend that puts lives in jeopardy. A ransomware attack could mean the difference between…
Continue ReadingResearchers at the Harvard Wyss Institute and the Dana-Farber Cancer Institute have developed a new method to prepare chimeric antigen receptor-T cells (CAR-T cells) for leukemia patients that could result in more effective treatment. CAR-T cells start life as T cells that are isolated from cancer patients, are stimulated and primed to recognize and attack cancer cells, expanded in number, and then reintroduced to the cancer patient with the goal that the cells will destroy their cancer. However, the technique works better in certain patients, and the researchers behind this latest technique have realized that T-cells from cancer patients do […]…
Continue Reading